Global Diabetes Personal Softwares Supply, Demand and Key Producers, 2024-2030

Global Diabetes Personal Softwares Supply, Demand and Key Producers, 2024-2030

Page: 143

Published Date: 18 Feb 2024

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Diabetes Personal Softwares market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.

Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.

This report studies the global Diabetes Personal Softwares demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Diabetes Personal Softwares, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Diabetes Personal Softwares that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Diabetes Personal Softwares total market, 2019-2030, (USD Million)
Global Diabetes Personal Softwares total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Diabetes Personal Softwares total market, key domestic companies and share, (USD Million)
Global Diabetes Personal Softwares revenue by player and market share 2019-2024, (USD Million)
Global Diabetes Personal Softwares total market by Type, CAGR, 2019-2030, (USD Million)
Global Diabetes Personal Softwares total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Diabetes Personal Softwares market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Glooko, Accu-Chek (Roche), Tidepool, LifeScan, Inc (Platinum Equity), Pharmaco Diabetes, Ascensia Diabetes Care Holdings AG, Diabeto Medtech India Pvt. Ltd and Abbott Diabetes Care, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Diabetes Personal Softwares market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Diabetes Personal Softwares Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Diabetes Personal Softwares Market, Segmentation by Type
Cloud-based
On-premise

Global Diabetes Personal Softwares Market, Segmentation by Application
Type I Diabetes
Type II Diabetes

Companies Profiled:
Medtronic
Glooko
Accu-Chek (Roche)
Tidepool
LifeScan, Inc (Platinum Equity)
Pharmaco Diabetes
Ascensia Diabetes Care Holdings AG
Diabeto Medtech India Pvt. Ltd
Abbott Diabetes Care
Acon Diabetes Care International
BIONIME
Custo med
Dexcom
Dottli
GlucoMe
MyLife
Nova
Tandem Diabetes Care
Trividia Health

Key Questions Answered
1. How big is the global Diabetes Personal Softwares market?
2. What is the demand of the global Diabetes Personal Softwares market?
3. What is the year over year growth of the global Diabetes Personal Softwares market?
4. What is the total value of the global Diabetes Personal Softwares market?
5. Who are the major players in the global Diabetes Personal Softwares market?
btl

Table of Contents

1 Supply Summary
1.1 Diabetes Personal Softwares Introduction
1.2 World Diabetes Personal Softwares Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Diabetes Personal Softwares Total Market by Region (by Headquarter Location)
1.3.1 World Diabetes Personal Softwares Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Diabetes Personal Softwares Market Size (2019-2030)
1.3.3 China Diabetes Personal Softwares Market Size (2019-2030)
1.3.4 Europe Diabetes Personal Softwares Market Size (2019-2030)
1.3.5 Japan Diabetes Personal Softwares Market Size (2019-2030)
1.3.6 South Korea Diabetes Personal Softwares Market Size (2019-2030)
1.3.7 ASEAN Diabetes Personal Softwares Market Size (2019-2030)
1.3.8 India Diabetes Personal Softwares Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Diabetes Personal Softwares Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Diabetes Personal Softwares Major Market Trends

2 Demand Summary
2.1 World Diabetes Personal Softwares Consumption Value (2019-2030)
2.2 World Diabetes Personal Softwares Consumption Value by Region
2.2.1 World Diabetes Personal Softwares Consumption Value by Region (2019-2024)
2.2.2 World Diabetes Personal Softwares Consumption Value Forecast by Region (2025-2030)
2.3 United States Diabetes Personal Softwares Consumption Value (2019-2030)
2.4 China Diabetes Personal Softwares Consumption Value (2019-2030)
2.5 Europe Diabetes Personal Softwares Consumption Value (2019-2030)
2.6 Japan Diabetes Personal Softwares Consumption Value (2019-2030)
2.7 South Korea Diabetes Personal Softwares Consumption Value (2019-2030)
2.8 ASEAN Diabetes Personal Softwares Consumption Value (2019-2030)
2.9 India Diabetes Personal Softwares Consumption Value (2019-2030)

3 World Diabetes Personal Softwares Companies Competitive Analysis
3.1 World Diabetes Personal Softwares Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Diabetes Personal Softwares Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Diabetes Personal Softwares in 2023
3.2.3 Global Concentration Ratios (CR8) for Diabetes Personal Softwares in 2023
3.3 Diabetes Personal Softwares Company Evaluation Quadrant
3.4 Diabetes Personal Softwares Market: Overall Company Footprint Analysis
3.4.1 Diabetes Personal Softwares Market: Region Footprint
3.4.2 Diabetes Personal Softwares Market: Company Product Type Footprint
3.4.3 Diabetes Personal Softwares Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: Diabetes Personal Softwares Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Diabetes Personal Softwares Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Diabetes Personal Softwares Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Diabetes Personal Softwares Consumption Value Comparison
4.2.1 United States VS China: Diabetes Personal Softwares Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Diabetes Personal Softwares Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Diabetes Personal Softwares Companies and Market Share, 2019-2024
4.3.1 United States Based Diabetes Personal Softwares Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Diabetes Personal Softwares Revenue, (2019-2024)
4.4 China Based Companies Diabetes Personal Softwares Revenue and Market Share, 2019-2024
4.4.1 China Based Diabetes Personal Softwares Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Diabetes Personal Softwares Revenue, (2019-2024)
4.5 Rest of World Based Diabetes Personal Softwares Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Diabetes Personal Softwares Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Diabetes Personal Softwares Revenue, (2019-2024)

5 Market Analysis by Type
5.1 World Diabetes Personal Softwares Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Cloud-based
5.2.2 On-premise
5.3 Market Segment by Type
5.3.1 World Diabetes Personal Softwares Market Size by Type (2019-2024)
5.3.2 World Diabetes Personal Softwares Market Size by Type (2025-2030)
5.3.3 World Diabetes Personal Softwares Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
6.1 World Diabetes Personal Softwares Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Type I Diabetes
6.2.2 Type II Diabetes
6.3 Market Segment by Application
6.3.1 World Diabetes Personal Softwares Market Size by Application (2019-2024)
6.3.2 World Diabetes Personal Softwares Market Size by Application (2025-2030)
6.3.3 World Diabetes Personal Softwares Market Size by Application (2019-2030)

7 Company Profiles
7.1 Medtronic
7.1.1 Medtronic Details
7.1.2 Medtronic Major Business
7.1.3 Medtronic Diabetes Personal Softwares Product and Services
7.1.4 Medtronic Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Medtronic Recent Developments/Updates
7.1.6 Medtronic Competitive Strengths & Weaknesses
7.2 Glooko
7.2.1 Glooko Details
7.2.2 Glooko Major Business
7.2.3 Glooko Diabetes Personal Softwares Product and Services
7.2.4 Glooko Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Glooko Recent Developments/Updates
7.2.6 Glooko Competitive Strengths & Weaknesses
7.3 Accu-Chek (Roche)
7.3.1 Accu-Chek (Roche) Details
7.3.2 Accu-Chek (Roche) Major Business
7.3.3 Accu-Chek (Roche) Diabetes Personal Softwares Product and Services
7.3.4 Accu-Chek (Roche) Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Accu-Chek (Roche) Recent Developments/Updates
7.3.6 Accu-Chek (Roche) Competitive Strengths & Weaknesses
7.4 Tidepool
7.4.1 Tidepool Details
7.4.2 Tidepool Major Business
7.4.3 Tidepool Diabetes Personal Softwares Product and Services
7.4.4 Tidepool Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 Tidepool Recent Developments/Updates
7.4.6 Tidepool Competitive Strengths & Weaknesses
7.5 LifeScan, Inc (Platinum Equity)
7.5.1 LifeScan, Inc (Platinum Equity) Details
7.5.2 LifeScan, Inc (Platinum Equity) Major Business
7.5.3 LifeScan, Inc (Platinum Equity) Diabetes Personal Softwares Product and Services
7.5.4 LifeScan, Inc (Platinum Equity) Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 LifeScan, Inc (Platinum Equity) Recent Developments/Updates
7.5.6 LifeScan, Inc (Platinum Equity) Competitive Strengths & Weaknesses
7.6 Pharmaco Diabetes
7.6.1 Pharmaco Diabetes Details
7.6.2 Pharmaco Diabetes Major Business
7.6.3 Pharmaco Diabetes Diabetes Personal Softwares Product and Services
7.6.4 Pharmaco Diabetes Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Pharmaco Diabetes Recent Developments/Updates
7.6.6 Pharmaco Diabetes Competitive Strengths & Weaknesses
7.7 Ascensia Diabetes Care Holdings AG
7.7.1 Ascensia Diabetes Care Holdings AG Details
7.7.2 Ascensia Diabetes Care Holdings AG Major Business
7.7.3 Ascensia Diabetes Care Holdings AG Diabetes Personal Softwares Product and Services
7.7.4 Ascensia Diabetes Care Holdings AG Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Ascensia Diabetes Care Holdings AG Recent Developments/Updates
7.7.6 Ascensia Diabetes Care Holdings AG Competitive Strengths & Weaknesses
7.8 Diabeto Medtech India Pvt. Ltd
7.8.1 Diabeto Medtech India Pvt. Ltd Details
7.8.2 Diabeto Medtech India Pvt. Ltd Major Business
7.8.3 Diabeto Medtech India Pvt. Ltd Diabetes Personal Softwares Product and Services
7.8.4 Diabeto Medtech India Pvt. Ltd Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Diabeto Medtech India Pvt. Ltd Recent Developments/Updates
7.8.6 Diabeto Medtech India Pvt. Ltd Competitive Strengths & Weaknesses
7.9 Abbott Diabetes Care
7.9.1 Abbott Diabetes Care Details
7.9.2 Abbott Diabetes Care Major Business
7.9.3 Abbott Diabetes Care Diabetes Personal Softwares Product and Services
7.9.4 Abbott Diabetes Care Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Abbott Diabetes Care Recent Developments/Updates
7.9.6 Abbott Diabetes Care Competitive Strengths & Weaknesses
7.10 Acon Diabetes Care International
7.10.1 Acon Diabetes Care International Details
7.10.2 Acon Diabetes Care International Major Business
7.10.3 Acon Diabetes Care International Diabetes Personal Softwares Product and Services
7.10.4 Acon Diabetes Care International Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 Acon Diabetes Care International Recent Developments/Updates
7.10.6 Acon Diabetes Care International Competitive Strengths & Weaknesses
7.11 BIONIME
7.11.1 BIONIME Details
7.11.2 BIONIME Major Business
7.11.3 BIONIME Diabetes Personal Softwares Product and Services
7.11.4 BIONIME Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 BIONIME Recent Developments/Updates
7.11.6 BIONIME Competitive Strengths & Weaknesses
7.12 Custo med
7.12.1 Custo med Details
7.12.2 Custo med Major Business
7.12.3 Custo med Diabetes Personal Softwares Product and Services
7.12.4 Custo med Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 Custo med Recent Developments/Updates
7.12.6 Custo med Competitive Strengths & Weaknesses
7.13 Dexcom
7.13.1 Dexcom Details
7.13.2 Dexcom Major Business
7.13.3 Dexcom Diabetes Personal Softwares Product and Services
7.13.4 Dexcom Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.13.5 Dexcom Recent Developments/Updates
7.13.6 Dexcom Competitive Strengths & Weaknesses
7.14 Dottli
7.14.1 Dottli Details
7.14.2 Dottli Major Business
7.14.3 Dottli Diabetes Personal Softwares Product and Services
7.14.4 Dottli Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.14.5 Dottli Recent Developments/Updates
7.14.6 Dottli Competitive Strengths & Weaknesses
7.15 GlucoMe
7.15.1 GlucoMe Details
7.15.2 GlucoMe Major Business
7.15.3 GlucoMe Diabetes Personal Softwares Product and Services
7.15.4 GlucoMe Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.15.5 GlucoMe Recent Developments/Updates
7.15.6 GlucoMe Competitive Strengths & Weaknesses
7.16 MyLife
7.16.1 MyLife Details
7.16.2 MyLife Major Business
7.16.3 MyLife Diabetes Personal Softwares Product and Services
7.16.4 MyLife Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.16.5 MyLife Recent Developments/Updates
7.16.6 MyLife Competitive Strengths & Weaknesses
7.17 Nova
7.17.1 Nova Details
7.17.2 Nova Major Business
7.17.3 Nova Diabetes Personal Softwares Product and Services
7.17.4 Nova Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.17.5 Nova Recent Developments/Updates
7.17.6 Nova Competitive Strengths & Weaknesses
7.18 Tandem Diabetes Care
7.18.1 Tandem Diabetes Care Details
7.18.2 Tandem Diabetes Care Major Business
7.18.3 Tandem Diabetes Care Diabetes Personal Softwares Product and Services
7.18.4 Tandem Diabetes Care Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.18.5 Tandem Diabetes Care Recent Developments/Updates
7.18.6 Tandem Diabetes Care Competitive Strengths & Weaknesses
7.19 Trividia Health
7.19.1 Trividia Health Details
7.19.2 Trividia Health Major Business
7.19.3 Trividia Health Diabetes Personal Softwares Product and Services
7.19.4 Trividia Health Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.19.5 Trividia Health Recent Developments/Updates
7.19.6 Trividia Health Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Diabetes Personal Softwares Industry Chain
8.2 Diabetes Personal Softwares Upstream Analysis
8.3 Diabetes Personal Softwares Midstream Analysis
8.4 Diabetes Personal Softwares Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Diabetes Personal Softwares Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Diabetes Personal Softwares Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Diabetes Personal Softwares Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Diabetes Personal Softwares Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Diabetes Personal Softwares Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Diabetes Personal Softwares Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Diabetes Personal Softwares Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Diabetes Personal Softwares Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Diabetes Personal Softwares Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Diabetes Personal Softwares Players in 2023
Table 12. World Diabetes Personal Softwares Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Diabetes Personal Softwares Company Evaluation Quadrant
Table 14. Head Office of Key Diabetes Personal Softwares Player
Table 15. Diabetes Personal Softwares Market: Company Product Type Footprint
Table 16. Diabetes Personal Softwares Market: Company Product Application Footprint
Table 17. Diabetes Personal Softwares Mergers & Acquisitions Activity
Table 18. United States VS China Diabetes Personal Softwares Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Diabetes Personal Softwares Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Diabetes Personal Softwares Companies, Headquarters (States, Country)
Table 21. United States Based Companies Diabetes Personal Softwares Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Diabetes Personal Softwares Revenue Market Share (2019-2024)
Table 23. China Based Diabetes Personal Softwares Companies, Headquarters (Province, Country)
Table 24. China Based Companies Diabetes Personal Softwares Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Diabetes Personal Softwares Revenue Market Share (2019-2024)
Table 26. Rest of World Based Diabetes Personal Softwares Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Diabetes Personal Softwares Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Diabetes Personal Softwares Revenue Market Share (2019-2024)
Table 29. World Diabetes Personal Softwares Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Diabetes Personal Softwares Market Size by Type (2019-2024) & (USD Million)
Table 31. World Diabetes Personal Softwares Market Size by Type (2025-2030) & (USD Million)
Table 32. World Diabetes Personal Softwares Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Diabetes Personal Softwares Market Size by Application (2019-2024) & (USD Million)
Table 34. World Diabetes Personal Softwares Market Size by Application (2025-2030) & (USD Million)
Table 35. Medtronic Basic Information, Area Served and Competitors
Table 36. Medtronic Major Business
Table 37. Medtronic Diabetes Personal Softwares Product and Services
Table 38. Medtronic Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Medtronic Recent Developments/Updates
Table 40. Medtronic Competitive Strengths & Weaknesses
Table 41. Glooko Basic Information, Area Served and Competitors
Table 42. Glooko Major Business
Table 43. Glooko Diabetes Personal Softwares Product and Services
Table 44. Glooko Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Glooko Recent Developments/Updates
Table 46. Glooko Competitive Strengths & Weaknesses
Table 47. Accu-Chek (Roche) Basic Information, Area Served and Competitors
Table 48. Accu-Chek (Roche) Major Business
Table 49. Accu-Chek (Roche) Diabetes Personal Softwares Product and Services
Table 50. Accu-Chek (Roche) Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Accu-Chek (Roche) Recent Developments/Updates
Table 52. Accu-Chek (Roche) Competitive Strengths & Weaknesses
Table 53. Tidepool Basic Information, Area Served and Competitors
Table 54. Tidepool Major Business
Table 55. Tidepool Diabetes Personal Softwares Product and Services
Table 56. Tidepool Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. Tidepool Recent Developments/Updates
Table 58. Tidepool Competitive Strengths & Weaknesses
Table 59. LifeScan, Inc (Platinum Equity) Basic Information, Area Served and Competitors
Table 60. LifeScan, Inc (Platinum Equity) Major Business
Table 61. LifeScan, Inc (Platinum Equity) Diabetes Personal Softwares Product and Services
Table 62. LifeScan, Inc (Platinum Equity) Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. LifeScan, Inc (Platinum Equity) Recent Developments/Updates
Table 64. LifeScan, Inc (Platinum Equity) Competitive Strengths & Weaknesses
Table 65. Pharmaco Diabetes Basic Information, Area Served and Competitors
Table 66. Pharmaco Diabetes Major Business
Table 67. Pharmaco Diabetes Diabetes Personal Softwares Product and Services
Table 68. Pharmaco Diabetes Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Pharmaco Diabetes Recent Developments/Updates
Table 70. Pharmaco Diabetes Competitive Strengths & Weaknesses
Table 71. Ascensia Diabetes Care Holdings AG Basic Information, Area Served and Competitors
Table 72. Ascensia Diabetes Care Holdings AG Major Business
Table 73. Ascensia Diabetes Care Holdings AG Diabetes Personal Softwares Product and Services
Table 74. Ascensia Diabetes Care Holdings AG Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Ascensia Diabetes Care Holdings AG Recent Developments/Updates
Table 76. Ascensia Diabetes Care Holdings AG Competitive Strengths & Weaknesses
Table 77. Diabeto Medtech India Pvt. Ltd Basic Information, Area Served and Competitors
Table 78. Diabeto Medtech India Pvt. Ltd Major Business
Table 79. Diabeto Medtech India Pvt. Ltd Diabetes Personal Softwares Product and Services
Table 80. Diabeto Medtech India Pvt. Ltd Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Diabeto Medtech India Pvt. Ltd Recent Developments/Updates
Table 82. Diabeto Medtech India Pvt. Ltd Competitive Strengths & Weaknesses
Table 83. Abbott Diabetes Care Basic Information, Area Served and Competitors
Table 84. Abbott Diabetes Care Major Business
Table 85. Abbott Diabetes Care Diabetes Personal Softwares Product and Services
Table 86. Abbott Diabetes Care Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Abbott Diabetes Care Recent Developments/Updates
Table 88. Abbott Diabetes Care Competitive Strengths & Weaknesses
Table 89. Acon Diabetes Care International Basic Information, Area Served and Competitors
Table 90. Acon Diabetes Care International Major Business
Table 91. Acon Diabetes Care International Diabetes Personal Softwares Product and Services
Table 92. Acon Diabetes Care International Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. Acon Diabetes Care International Recent Developments/Updates
Table 94. Acon Diabetes Care International Competitive Strengths & Weaknesses
Table 95. BIONIME Basic Information, Area Served and Competitors
Table 96. BIONIME Major Business
Table 97. BIONIME Diabetes Personal Softwares Product and Services
Table 98. BIONIME Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. BIONIME Recent Developments/Updates
Table 100. BIONIME Competitive Strengths & Weaknesses
Table 101. Custo med Basic Information, Area Served and Competitors
Table 102. Custo med Major Business
Table 103. Custo med Diabetes Personal Softwares Product and Services
Table 104. Custo med Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 105. Custo med Recent Developments/Updates
Table 106. Custo med Competitive Strengths & Weaknesses
Table 107. Dexcom Basic Information, Area Served and Competitors
Table 108. Dexcom Major Business
Table 109. Dexcom Diabetes Personal Softwares Product and Services
Table 110. Dexcom Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 111. Dexcom Recent Developments/Updates
Table 112. Dexcom Competitive Strengths & Weaknesses
Table 113. Dottli Basic Information, Area Served and Competitors
Table 114. Dottli Major Business
Table 115. Dottli Diabetes Personal Softwares Product and Services
Table 116. Dottli Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 117. Dottli Recent Developments/Updates
Table 118. Dottli Competitive Strengths & Weaknesses
Table 119. GlucoMe Basic Information, Area Served and Competitors
Table 120. GlucoMe Major Business
Table 121. GlucoMe Diabetes Personal Softwares Product and Services
Table 122. GlucoMe Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 123. GlucoMe Recent Developments/Updates
Table 124. GlucoMe Competitive Strengths & Weaknesses
Table 125. MyLife Basic Information, Area Served and Competitors
Table 126. MyLife Major Business
Table 127. MyLife Diabetes Personal Softwares Product and Services
Table 128. MyLife Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 129. MyLife Recent Developments/Updates
Table 130. MyLife Competitive Strengths & Weaknesses
Table 131. Nova Basic Information, Area Served and Competitors
Table 132. Nova Major Business
Table 133. Nova Diabetes Personal Softwares Product and Services
Table 134. Nova Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 135. Nova Recent Developments/Updates
Table 136. Nova Competitive Strengths & Weaknesses
Table 137. Tandem Diabetes Care Basic Information, Area Served and Competitors
Table 138. Tandem Diabetes Care Major Business
Table 139. Tandem Diabetes Care Diabetes Personal Softwares Product and Services
Table 140. Tandem Diabetes Care Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 141. Tandem Diabetes Care Recent Developments/Updates
Table 142. Trividia Health Basic Information, Area Served and Competitors
Table 143. Trividia Health Major Business
Table 144. Trividia Health Diabetes Personal Softwares Product and Services
Table 145. Trividia Health Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 146. Global Key Players of Diabetes Personal Softwares Upstream (Raw Materials)
Table 147. Diabetes Personal Softwares Typical Customers
List of Figure
Figure 1. Diabetes Personal Softwares Picture
Figure 2. World Diabetes Personal Softwares Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Diabetes Personal Softwares Total Market Size (2019-2030) & (USD Million)
Figure 4. World Diabetes Personal Softwares Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Diabetes Personal Softwares Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Diabetes Personal Softwares Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Diabetes Personal Softwares Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Diabetes Personal Softwares Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Diabetes Personal Softwares Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Diabetes Personal Softwares Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Diabetes Personal Softwares Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Diabetes Personal Softwares Revenue (2019-2030) & (USD Million)
Figure 13. Diabetes Personal Softwares Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Diabetes Personal Softwares Consumption Value (2019-2030) & (USD Million)
Figure 16. World Diabetes Personal Softwares Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Diabetes Personal Softwares Consumption Value (2019-2030) & (USD Million)
Figure 18. China Diabetes Personal Softwares Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Diabetes Personal Softwares Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Diabetes Personal Softwares Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Diabetes Personal Softwares Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Diabetes Personal Softwares Consumption Value (2019-2030) & (USD Million)
Figure 23. India Diabetes Personal Softwares Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Diabetes Personal Softwares by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Diabetes Personal Softwares Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Diabetes Personal Softwares Markets in 2023
Figure 27. United States VS China: Diabetes Personal Softwares Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Diabetes Personal Softwares Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Diabetes Personal Softwares Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Diabetes Personal Softwares Market Size Market Share by Type in 2023
Figure 31. Cloud-based
Figure 32. On-premise
Figure 33. World Diabetes Personal Softwares Market Size Market Share by Type (2019-2030)
Figure 34. World Diabetes Personal Softwares Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 35. World Diabetes Personal Softwares Market Size Market Share by Application in 2023
Figure 36. Type I Diabetes
Figure 37. Type II Diabetes
Figure 38. Diabetes Personal Softwares Industrial Chain
Figure 39. Methodology
Figure 40. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Medtronic
Glooko
Accu-Chek (Roche)
Tidepool
LifeScan, Inc (Platinum Equity)
Pharmaco Diabetes
Ascensia Diabetes Care Holdings AG
Diabeto Medtech India Pvt. Ltd
Abbott Diabetes Care
Acon Diabetes Care International
BIONIME
Custo med
Dexcom
Dottli
GlucoMe
MyLife
Nova
Tandem Diabetes Care
Trividia Health
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Diabetes Personal Softwares Supply, Demand and Key Producers, 2024-2030

Global Diabetes Personal Softwares Supply, Demand and Key Producers, 2024-2030

Page: 143

Published Date: 18 Feb 2024

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Diabetes Personal Softwares market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.

Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.

This report studies the global Diabetes Personal Softwares demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Diabetes Personal Softwares, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Diabetes Personal Softwares that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Diabetes Personal Softwares total market, 2019-2030, (USD Million)
Global Diabetes Personal Softwares total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Diabetes Personal Softwares total market, key domestic companies and share, (USD Million)
Global Diabetes Personal Softwares revenue by player and market share 2019-2024, (USD Million)
Global Diabetes Personal Softwares total market by Type, CAGR, 2019-2030, (USD Million)
Global Diabetes Personal Softwares total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Diabetes Personal Softwares market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Glooko, Accu-Chek (Roche), Tidepool, LifeScan, Inc (Platinum Equity), Pharmaco Diabetes, Ascensia Diabetes Care Holdings AG, Diabeto Medtech India Pvt. Ltd and Abbott Diabetes Care, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Diabetes Personal Softwares market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Diabetes Personal Softwares Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Diabetes Personal Softwares Market, Segmentation by Type
Cloud-based
On-premise

Global Diabetes Personal Softwares Market, Segmentation by Application
Type I Diabetes
Type II Diabetes

Companies Profiled:
Medtronic
Glooko
Accu-Chek (Roche)
Tidepool
LifeScan, Inc (Platinum Equity)
Pharmaco Diabetes
Ascensia Diabetes Care Holdings AG
Diabeto Medtech India Pvt. Ltd
Abbott Diabetes Care
Acon Diabetes Care International
BIONIME
Custo med
Dexcom
Dottli
GlucoMe
MyLife
Nova
Tandem Diabetes Care
Trividia Health

Key Questions Answered
1. How big is the global Diabetes Personal Softwares market?
2. What is the demand of the global Diabetes Personal Softwares market?
3. What is the year over year growth of the global Diabetes Personal Softwares market?
4. What is the total value of the global Diabetes Personal Softwares market?
5. Who are the major players in the global Diabetes Personal Softwares market?
btl

Table of Contents

1 Supply Summary
1.1 Diabetes Personal Softwares Introduction
1.2 World Diabetes Personal Softwares Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Diabetes Personal Softwares Total Market by Region (by Headquarter Location)
1.3.1 World Diabetes Personal Softwares Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Diabetes Personal Softwares Market Size (2019-2030)
1.3.3 China Diabetes Personal Softwares Market Size (2019-2030)
1.3.4 Europe Diabetes Personal Softwares Market Size (2019-2030)
1.3.5 Japan Diabetes Personal Softwares Market Size (2019-2030)
1.3.6 South Korea Diabetes Personal Softwares Market Size (2019-2030)
1.3.7 ASEAN Diabetes Personal Softwares Market Size (2019-2030)
1.3.8 India Diabetes Personal Softwares Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Diabetes Personal Softwares Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Diabetes Personal Softwares Major Market Trends

2 Demand Summary
2.1 World Diabetes Personal Softwares Consumption Value (2019-2030)
2.2 World Diabetes Personal Softwares Consumption Value by Region
2.2.1 World Diabetes Personal Softwares Consumption Value by Region (2019-2024)
2.2.2 World Diabetes Personal Softwares Consumption Value Forecast by Region (2025-2030)
2.3 United States Diabetes Personal Softwares Consumption Value (2019-2030)
2.4 China Diabetes Personal Softwares Consumption Value (2019-2030)
2.5 Europe Diabetes Personal Softwares Consumption Value (2019-2030)
2.6 Japan Diabetes Personal Softwares Consumption Value (2019-2030)
2.7 South Korea Diabetes Personal Softwares Consumption Value (2019-2030)
2.8 ASEAN Diabetes Personal Softwares Consumption Value (2019-2030)
2.9 India Diabetes Personal Softwares Consumption Value (2019-2030)

3 World Diabetes Personal Softwares Companies Competitive Analysis
3.1 World Diabetes Personal Softwares Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Diabetes Personal Softwares Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Diabetes Personal Softwares in 2023
3.2.3 Global Concentration Ratios (CR8) for Diabetes Personal Softwares in 2023
3.3 Diabetes Personal Softwares Company Evaluation Quadrant
3.4 Diabetes Personal Softwares Market: Overall Company Footprint Analysis
3.4.1 Diabetes Personal Softwares Market: Region Footprint
3.4.2 Diabetes Personal Softwares Market: Company Product Type Footprint
3.4.3 Diabetes Personal Softwares Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: Diabetes Personal Softwares Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Diabetes Personal Softwares Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Diabetes Personal Softwares Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Diabetes Personal Softwares Consumption Value Comparison
4.2.1 United States VS China: Diabetes Personal Softwares Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Diabetes Personal Softwares Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Diabetes Personal Softwares Companies and Market Share, 2019-2024
4.3.1 United States Based Diabetes Personal Softwares Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Diabetes Personal Softwares Revenue, (2019-2024)
4.4 China Based Companies Diabetes Personal Softwares Revenue and Market Share, 2019-2024
4.4.1 China Based Diabetes Personal Softwares Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Diabetes Personal Softwares Revenue, (2019-2024)
4.5 Rest of World Based Diabetes Personal Softwares Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Diabetes Personal Softwares Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Diabetes Personal Softwares Revenue, (2019-2024)

5 Market Analysis by Type
5.1 World Diabetes Personal Softwares Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Cloud-based
5.2.2 On-premise
5.3 Market Segment by Type
5.3.1 World Diabetes Personal Softwares Market Size by Type (2019-2024)
5.3.2 World Diabetes Personal Softwares Market Size by Type (2025-2030)
5.3.3 World Diabetes Personal Softwares Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
6.1 World Diabetes Personal Softwares Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Type I Diabetes
6.2.2 Type II Diabetes
6.3 Market Segment by Application
6.3.1 World Diabetes Personal Softwares Market Size by Application (2019-2024)
6.3.2 World Diabetes Personal Softwares Market Size by Application (2025-2030)
6.3.3 World Diabetes Personal Softwares Market Size by Application (2019-2030)

7 Company Profiles
7.1 Medtronic
7.1.1 Medtronic Details
7.1.2 Medtronic Major Business
7.1.3 Medtronic Diabetes Personal Softwares Product and Services
7.1.4 Medtronic Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Medtronic Recent Developments/Updates
7.1.6 Medtronic Competitive Strengths & Weaknesses
7.2 Glooko
7.2.1 Glooko Details
7.2.2 Glooko Major Business
7.2.3 Glooko Diabetes Personal Softwares Product and Services
7.2.4 Glooko Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Glooko Recent Developments/Updates
7.2.6 Glooko Competitive Strengths & Weaknesses
7.3 Accu-Chek (Roche)
7.3.1 Accu-Chek (Roche) Details
7.3.2 Accu-Chek (Roche) Major Business
7.3.3 Accu-Chek (Roche) Diabetes Personal Softwares Product and Services
7.3.4 Accu-Chek (Roche) Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Accu-Chek (Roche) Recent Developments/Updates
7.3.6 Accu-Chek (Roche) Competitive Strengths & Weaknesses
7.4 Tidepool
7.4.1 Tidepool Details
7.4.2 Tidepool Major Business
7.4.3 Tidepool Diabetes Personal Softwares Product and Services
7.4.4 Tidepool Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 Tidepool Recent Developments/Updates
7.4.6 Tidepool Competitive Strengths & Weaknesses
7.5 LifeScan, Inc (Platinum Equity)
7.5.1 LifeScan, Inc (Platinum Equity) Details
7.5.2 LifeScan, Inc (Platinum Equity) Major Business
7.5.3 LifeScan, Inc (Platinum Equity) Diabetes Personal Softwares Product and Services
7.5.4 LifeScan, Inc (Platinum Equity) Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 LifeScan, Inc (Platinum Equity) Recent Developments/Updates
7.5.6 LifeScan, Inc (Platinum Equity) Competitive Strengths & Weaknesses
7.6 Pharmaco Diabetes
7.6.1 Pharmaco Diabetes Details
7.6.2 Pharmaco Diabetes Major Business
7.6.3 Pharmaco Diabetes Diabetes Personal Softwares Product and Services
7.6.4 Pharmaco Diabetes Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Pharmaco Diabetes Recent Developments/Updates
7.6.6 Pharmaco Diabetes Competitive Strengths & Weaknesses
7.7 Ascensia Diabetes Care Holdings AG
7.7.1 Ascensia Diabetes Care Holdings AG Details
7.7.2 Ascensia Diabetes Care Holdings AG Major Business
7.7.3 Ascensia Diabetes Care Holdings AG Diabetes Personal Softwares Product and Services
7.7.4 Ascensia Diabetes Care Holdings AG Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Ascensia Diabetes Care Holdings AG Recent Developments/Updates
7.7.6 Ascensia Diabetes Care Holdings AG Competitive Strengths & Weaknesses
7.8 Diabeto Medtech India Pvt. Ltd
7.8.1 Diabeto Medtech India Pvt. Ltd Details
7.8.2 Diabeto Medtech India Pvt. Ltd Major Business
7.8.3 Diabeto Medtech India Pvt. Ltd Diabetes Personal Softwares Product and Services
7.8.4 Diabeto Medtech India Pvt. Ltd Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Diabeto Medtech India Pvt. Ltd Recent Developments/Updates
7.8.6 Diabeto Medtech India Pvt. Ltd Competitive Strengths & Weaknesses
7.9 Abbott Diabetes Care
7.9.1 Abbott Diabetes Care Details
7.9.2 Abbott Diabetes Care Major Business
7.9.3 Abbott Diabetes Care Diabetes Personal Softwares Product and Services
7.9.4 Abbott Diabetes Care Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Abbott Diabetes Care Recent Developments/Updates
7.9.6 Abbott Diabetes Care Competitive Strengths & Weaknesses
7.10 Acon Diabetes Care International
7.10.1 Acon Diabetes Care International Details
7.10.2 Acon Diabetes Care International Major Business
7.10.3 Acon Diabetes Care International Diabetes Personal Softwares Product and Services
7.10.4 Acon Diabetes Care International Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 Acon Diabetes Care International Recent Developments/Updates
7.10.6 Acon Diabetes Care International Competitive Strengths & Weaknesses
7.11 BIONIME
7.11.1 BIONIME Details
7.11.2 BIONIME Major Business
7.11.3 BIONIME Diabetes Personal Softwares Product and Services
7.11.4 BIONIME Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 BIONIME Recent Developments/Updates
7.11.6 BIONIME Competitive Strengths & Weaknesses
7.12 Custo med
7.12.1 Custo med Details
7.12.2 Custo med Major Business
7.12.3 Custo med Diabetes Personal Softwares Product and Services
7.12.4 Custo med Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 Custo med Recent Developments/Updates
7.12.6 Custo med Competitive Strengths & Weaknesses
7.13 Dexcom
7.13.1 Dexcom Details
7.13.2 Dexcom Major Business
7.13.3 Dexcom Diabetes Personal Softwares Product and Services
7.13.4 Dexcom Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.13.5 Dexcom Recent Developments/Updates
7.13.6 Dexcom Competitive Strengths & Weaknesses
7.14 Dottli
7.14.1 Dottli Details
7.14.2 Dottli Major Business
7.14.3 Dottli Diabetes Personal Softwares Product and Services
7.14.4 Dottli Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.14.5 Dottli Recent Developments/Updates
7.14.6 Dottli Competitive Strengths & Weaknesses
7.15 GlucoMe
7.15.1 GlucoMe Details
7.15.2 GlucoMe Major Business
7.15.3 GlucoMe Diabetes Personal Softwares Product and Services
7.15.4 GlucoMe Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.15.5 GlucoMe Recent Developments/Updates
7.15.6 GlucoMe Competitive Strengths & Weaknesses
7.16 MyLife
7.16.1 MyLife Details
7.16.2 MyLife Major Business
7.16.3 MyLife Diabetes Personal Softwares Product and Services
7.16.4 MyLife Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.16.5 MyLife Recent Developments/Updates
7.16.6 MyLife Competitive Strengths & Weaknesses
7.17 Nova
7.17.1 Nova Details
7.17.2 Nova Major Business
7.17.3 Nova Diabetes Personal Softwares Product and Services
7.17.4 Nova Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.17.5 Nova Recent Developments/Updates
7.17.6 Nova Competitive Strengths & Weaknesses
7.18 Tandem Diabetes Care
7.18.1 Tandem Diabetes Care Details
7.18.2 Tandem Diabetes Care Major Business
7.18.3 Tandem Diabetes Care Diabetes Personal Softwares Product and Services
7.18.4 Tandem Diabetes Care Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.18.5 Tandem Diabetes Care Recent Developments/Updates
7.18.6 Tandem Diabetes Care Competitive Strengths & Weaknesses
7.19 Trividia Health
7.19.1 Trividia Health Details
7.19.2 Trividia Health Major Business
7.19.3 Trividia Health Diabetes Personal Softwares Product and Services
7.19.4 Trividia Health Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024)
7.19.5 Trividia Health Recent Developments/Updates
7.19.6 Trividia Health Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Diabetes Personal Softwares Industry Chain
8.2 Diabetes Personal Softwares Upstream Analysis
8.3 Diabetes Personal Softwares Midstream Analysis
8.4 Diabetes Personal Softwares Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Diabetes Personal Softwares Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Diabetes Personal Softwares Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Diabetes Personal Softwares Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Diabetes Personal Softwares Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Diabetes Personal Softwares Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Diabetes Personal Softwares Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Diabetes Personal Softwares Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Diabetes Personal Softwares Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Diabetes Personal Softwares Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Diabetes Personal Softwares Players in 2023
Table 12. World Diabetes Personal Softwares Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Diabetes Personal Softwares Company Evaluation Quadrant
Table 14. Head Office of Key Diabetes Personal Softwares Player
Table 15. Diabetes Personal Softwares Market: Company Product Type Footprint
Table 16. Diabetes Personal Softwares Market: Company Product Application Footprint
Table 17. Diabetes Personal Softwares Mergers & Acquisitions Activity
Table 18. United States VS China Diabetes Personal Softwares Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Diabetes Personal Softwares Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Diabetes Personal Softwares Companies, Headquarters (States, Country)
Table 21. United States Based Companies Diabetes Personal Softwares Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Diabetes Personal Softwares Revenue Market Share (2019-2024)
Table 23. China Based Diabetes Personal Softwares Companies, Headquarters (Province, Country)
Table 24. China Based Companies Diabetes Personal Softwares Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Diabetes Personal Softwares Revenue Market Share (2019-2024)
Table 26. Rest of World Based Diabetes Personal Softwares Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Diabetes Personal Softwares Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Diabetes Personal Softwares Revenue Market Share (2019-2024)
Table 29. World Diabetes Personal Softwares Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Diabetes Personal Softwares Market Size by Type (2019-2024) & (USD Million)
Table 31. World Diabetes Personal Softwares Market Size by Type (2025-2030) & (USD Million)
Table 32. World Diabetes Personal Softwares Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Diabetes Personal Softwares Market Size by Application (2019-2024) & (USD Million)
Table 34. World Diabetes Personal Softwares Market Size by Application (2025-2030) & (USD Million)
Table 35. Medtronic Basic Information, Area Served and Competitors
Table 36. Medtronic Major Business
Table 37. Medtronic Diabetes Personal Softwares Product and Services
Table 38. Medtronic Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Medtronic Recent Developments/Updates
Table 40. Medtronic Competitive Strengths & Weaknesses
Table 41. Glooko Basic Information, Area Served and Competitors
Table 42. Glooko Major Business
Table 43. Glooko Diabetes Personal Softwares Product and Services
Table 44. Glooko Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Glooko Recent Developments/Updates
Table 46. Glooko Competitive Strengths & Weaknesses
Table 47. Accu-Chek (Roche) Basic Information, Area Served and Competitors
Table 48. Accu-Chek (Roche) Major Business
Table 49. Accu-Chek (Roche) Diabetes Personal Softwares Product and Services
Table 50. Accu-Chek (Roche) Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Accu-Chek (Roche) Recent Developments/Updates
Table 52. Accu-Chek (Roche) Competitive Strengths & Weaknesses
Table 53. Tidepool Basic Information, Area Served and Competitors
Table 54. Tidepool Major Business
Table 55. Tidepool Diabetes Personal Softwares Product and Services
Table 56. Tidepool Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. Tidepool Recent Developments/Updates
Table 58. Tidepool Competitive Strengths & Weaknesses
Table 59. LifeScan, Inc (Platinum Equity) Basic Information, Area Served and Competitors
Table 60. LifeScan, Inc (Platinum Equity) Major Business
Table 61. LifeScan, Inc (Platinum Equity) Diabetes Personal Softwares Product and Services
Table 62. LifeScan, Inc (Platinum Equity) Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. LifeScan, Inc (Platinum Equity) Recent Developments/Updates
Table 64. LifeScan, Inc (Platinum Equity) Competitive Strengths & Weaknesses
Table 65. Pharmaco Diabetes Basic Information, Area Served and Competitors
Table 66. Pharmaco Diabetes Major Business
Table 67. Pharmaco Diabetes Diabetes Personal Softwares Product and Services
Table 68. Pharmaco Diabetes Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Pharmaco Diabetes Recent Developments/Updates
Table 70. Pharmaco Diabetes Competitive Strengths & Weaknesses
Table 71. Ascensia Diabetes Care Holdings AG Basic Information, Area Served and Competitors
Table 72. Ascensia Diabetes Care Holdings AG Major Business
Table 73. Ascensia Diabetes Care Holdings AG Diabetes Personal Softwares Product and Services
Table 74. Ascensia Diabetes Care Holdings AG Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Ascensia Diabetes Care Holdings AG Recent Developments/Updates
Table 76. Ascensia Diabetes Care Holdings AG Competitive Strengths & Weaknesses
Table 77. Diabeto Medtech India Pvt. Ltd Basic Information, Area Served and Competitors
Table 78. Diabeto Medtech India Pvt. Ltd Major Business
Table 79. Diabeto Medtech India Pvt. Ltd Diabetes Personal Softwares Product and Services
Table 80. Diabeto Medtech India Pvt. Ltd Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Diabeto Medtech India Pvt. Ltd Recent Developments/Updates
Table 82. Diabeto Medtech India Pvt. Ltd Competitive Strengths & Weaknesses
Table 83. Abbott Diabetes Care Basic Information, Area Served and Competitors
Table 84. Abbott Diabetes Care Major Business
Table 85. Abbott Diabetes Care Diabetes Personal Softwares Product and Services
Table 86. Abbott Diabetes Care Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Abbott Diabetes Care Recent Developments/Updates
Table 88. Abbott Diabetes Care Competitive Strengths & Weaknesses
Table 89. Acon Diabetes Care International Basic Information, Area Served and Competitors
Table 90. Acon Diabetes Care International Major Business
Table 91. Acon Diabetes Care International Diabetes Personal Softwares Product and Services
Table 92. Acon Diabetes Care International Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. Acon Diabetes Care International Recent Developments/Updates
Table 94. Acon Diabetes Care International Competitive Strengths & Weaknesses
Table 95. BIONIME Basic Information, Area Served and Competitors
Table 96. BIONIME Major Business
Table 97. BIONIME Diabetes Personal Softwares Product and Services
Table 98. BIONIME Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. BIONIME Recent Developments/Updates
Table 100. BIONIME Competitive Strengths & Weaknesses
Table 101. Custo med Basic Information, Area Served and Competitors
Table 102. Custo med Major Business
Table 103. Custo med Diabetes Personal Softwares Product and Services
Table 104. Custo med Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 105. Custo med Recent Developments/Updates
Table 106. Custo med Competitive Strengths & Weaknesses
Table 107. Dexcom Basic Information, Area Served and Competitors
Table 108. Dexcom Major Business
Table 109. Dexcom Diabetes Personal Softwares Product and Services
Table 110. Dexcom Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 111. Dexcom Recent Developments/Updates
Table 112. Dexcom Competitive Strengths & Weaknesses
Table 113. Dottli Basic Information, Area Served and Competitors
Table 114. Dottli Major Business
Table 115. Dottli Diabetes Personal Softwares Product and Services
Table 116. Dottli Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 117. Dottli Recent Developments/Updates
Table 118. Dottli Competitive Strengths & Weaknesses
Table 119. GlucoMe Basic Information, Area Served and Competitors
Table 120. GlucoMe Major Business
Table 121. GlucoMe Diabetes Personal Softwares Product and Services
Table 122. GlucoMe Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 123. GlucoMe Recent Developments/Updates
Table 124. GlucoMe Competitive Strengths & Weaknesses
Table 125. MyLife Basic Information, Area Served and Competitors
Table 126. MyLife Major Business
Table 127. MyLife Diabetes Personal Softwares Product and Services
Table 128. MyLife Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 129. MyLife Recent Developments/Updates
Table 130. MyLife Competitive Strengths & Weaknesses
Table 131. Nova Basic Information, Area Served and Competitors
Table 132. Nova Major Business
Table 133. Nova Diabetes Personal Softwares Product and Services
Table 134. Nova Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 135. Nova Recent Developments/Updates
Table 136. Nova Competitive Strengths & Weaknesses
Table 137. Tandem Diabetes Care Basic Information, Area Served and Competitors
Table 138. Tandem Diabetes Care Major Business
Table 139. Tandem Diabetes Care Diabetes Personal Softwares Product and Services
Table 140. Tandem Diabetes Care Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 141. Tandem Diabetes Care Recent Developments/Updates
Table 142. Trividia Health Basic Information, Area Served and Competitors
Table 143. Trividia Health Major Business
Table 144. Trividia Health Diabetes Personal Softwares Product and Services
Table 145. Trividia Health Diabetes Personal Softwares Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 146. Global Key Players of Diabetes Personal Softwares Upstream (Raw Materials)
Table 147. Diabetes Personal Softwares Typical Customers
List of Figure
Figure 1. Diabetes Personal Softwares Picture
Figure 2. World Diabetes Personal Softwares Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Diabetes Personal Softwares Total Market Size (2019-2030) & (USD Million)
Figure 4. World Diabetes Personal Softwares Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Diabetes Personal Softwares Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Diabetes Personal Softwares Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Diabetes Personal Softwares Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Diabetes Personal Softwares Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Diabetes Personal Softwares Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Diabetes Personal Softwares Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Diabetes Personal Softwares Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Diabetes Personal Softwares Revenue (2019-2030) & (USD Million)
Figure 13. Diabetes Personal Softwares Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Diabetes Personal Softwares Consumption Value (2019-2030) & (USD Million)
Figure 16. World Diabetes Personal Softwares Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Diabetes Personal Softwares Consumption Value (2019-2030) & (USD Million)
Figure 18. China Diabetes Personal Softwares Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Diabetes Personal Softwares Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Diabetes Personal Softwares Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Diabetes Personal Softwares Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Diabetes Personal Softwares Consumption Value (2019-2030) & (USD Million)
Figure 23. India Diabetes Personal Softwares Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Diabetes Personal Softwares by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Diabetes Personal Softwares Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Diabetes Personal Softwares Markets in 2023
Figure 27. United States VS China: Diabetes Personal Softwares Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Diabetes Personal Softwares Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Diabetes Personal Softwares Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Diabetes Personal Softwares Market Size Market Share by Type in 2023
Figure 31. Cloud-based
Figure 32. On-premise
Figure 33. World Diabetes Personal Softwares Market Size Market Share by Type (2019-2030)
Figure 34. World Diabetes Personal Softwares Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 35. World Diabetes Personal Softwares Market Size Market Share by Application in 2023
Figure 36. Type I Diabetes
Figure 37. Type II Diabetes
Figure 38. Diabetes Personal Softwares Industrial Chain
Figure 39. Methodology
Figure 40. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Medtronic
Glooko
Accu-Chek (Roche)
Tidepool
LifeScan, Inc (Platinum Equity)
Pharmaco Diabetes
Ascensia Diabetes Care Holdings AG
Diabeto Medtech India Pvt. Ltd
Abbott Diabetes Care
Acon Diabetes Care International
BIONIME
Custo med
Dexcom
Dottli
GlucoMe
MyLife
Nova
Tandem Diabetes Care
Trividia Health
jiaGou

Add To Cart

gouMai

Buy Now